DK153494C - Analogifremgangsmaade til fremstilling af 3,20-dioxo-7alfa-halogen-1,4-pregnadiener - Google Patents

Analogifremgangsmaade til fremstilling af 3,20-dioxo-7alfa-halogen-1,4-pregnadiener

Info

Publication number
DK153494C
DK153494C DK569977A DK569977A DK153494C DK 153494 C DK153494 C DK 153494C DK 569977 A DK569977 A DK 569977A DK 569977 A DK569977 A DK 569977A DK 153494 C DK153494 C DK 153494C
Authority
DK
Denmark
Prior art keywords
7alfa
dioxo
pregnancy
halogen
preparing
Prior art date
Application number
DK569977A
Other languages
Danish (da)
English (en)
Other versions
DK153494B (da
DK569977A (da
Inventor
Michael John Green
Ho-Jane Shue
Elliot Lewis Shapiro
Margaret Anne Gentles
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/753,257 external-priority patent/US4076708A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of DK569977A publication Critical patent/DK569977A/da
Publication of DK153494B publication Critical patent/DK153494B/da
Application granted granted Critical
Publication of DK153494C publication Critical patent/DK153494C/da

Links

Classifications

    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G11/00—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs
    • E04G11/06—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs for walls, e.g. curved end panels for wall shutterings; filler elements for wall shutterings; shutterings for vertical ducts
    • E04G11/20—Movable forms; Movable forms for moulding cylindrical, conical or hyperbolical structures; Templates serving as forms for positioning blocks or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G17/00—Connecting or other auxiliary members for forms, falsework structures, or shutterings
    • E04G17/14—Bracing or strutting arrangements for formwalls; Devices for aligning forms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Architecture (AREA)
  • Engineering & Computer Science (AREA)
  • Civil Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Structural Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DK569977A 1976-12-22 1977-12-20 Analogifremgangsmaade til fremstilling af 3,20-dioxo-7alfa-halogen-1,4-pregnadiener DK153494C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75325676A 1976-12-22 1976-12-22
US05/753,257 US4076708A (en) 1976-12-22 1976-12-22 Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby
US75325676 1976-12-22
US75325776 1976-12-22

Publications (3)

Publication Number Publication Date
DK569977A DK569977A (da) 1978-09-28
DK153494B DK153494B (da) 1988-07-18
DK153494C true DK153494C (da) 1989-02-20

Family

ID=27115720

Family Applications (1)

Application Number Title Priority Date Filing Date
DK569977A DK153494C (da) 1976-12-22 1977-12-20 Analogifremgangsmaade til fremstilling af 3,20-dioxo-7alfa-halogen-1,4-pregnadiener

Country Status (20)

Country Link
JP (1) JPS604198B2 (no)
AR (1) AR226806A1 (no)
AT (2) AT373269B (no)
BE (1) BE862089A (no)
DE (1) DE2756550C2 (no)
DK (1) DK153494C (no)
FI (1) FI63947C (no)
FR (1) FR2384793A1 (no)
GB (1) GB1575983A (no)
HK (1) HK584A (no)
HU (1) HU179784B (no)
IE (1) IE45950B1 (no)
IL (1) IL53636A (no)
MY (1) MY8500082A (no)
NL (1) NL180479C (no)
NO (1) NO151826C (no)
NZ (1) NZ186031A (no)
PT (1) PT67432B (no)
SE (1) SE429865B (no)
SG (1) SG58683G (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109680036A (zh) 2017-10-02 2019-04-26 爱科来株式会社 糖化蛋白质的测定

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429926A (en) * 1964-05-25 1969-02-25 Squibb & Sons Inc 7-halo and 6-halo,6-dehydro a-norprogesterones

Also Published As

Publication number Publication date
NL180479C (nl) 1987-03-02
MY8500082A (en) 1985-12-31
IL53636A (en) 1983-05-15
FI773825A (fi) 1978-06-23
PT67432A (en) 1978-01-01
DK153494B (da) 1988-07-18
DE2756550A1 (de) 1978-07-06
JPS604198B2 (ja) 1985-02-01
SE7714538L (sv) 1978-06-23
NO151826C (no) 1985-06-12
HU179784B (en) 1982-12-28
FI63947C (fi) 1983-09-12
DE2756550C2 (de) 1986-10-16
BE862089A (fr) 1978-06-20
DK569977A (da) 1978-09-28
AR226806A1 (es) 1982-08-31
IL53636A0 (en) 1978-03-10
NO774359L (no) 1978-06-23
IE45950B1 (en) 1983-01-12
ATA575980A (de) 1982-04-15
IE45950L (en) 1978-06-22
NL180479B (nl) 1986-10-01
NL7714056A (nl) 1978-06-26
NO151826B (no) 1985-03-04
NZ186031A (en) 1984-07-31
AT377566B (de) 1985-04-10
FR2384793A1 (fr) 1978-10-20
PT67432B (en) 1979-05-23
AT373269B (de) 1984-01-10
JPS5379850A (en) 1978-07-14
SE429865B (sv) 1983-10-03
SG58683G (en) 1985-01-11
GB1575983A (en) 1980-10-01
FR2384793B1 (no) 1981-11-13
FI63947B (fi) 1983-05-31
ATA909477A (de) 1983-05-15
HK584A (en) 1984-01-13

Similar Documents

Publication Publication Date Title
DK149749C (da) Analogifremgangsmaade til fremstilling af n-alkyl-2-hydroxy-metyl-3,4,5-trihydroxy-piperidinderivater
DK153552C (da) Analogifremgangsmaade til fremstilling af 1,8-naphthyridinderivater
DK155946C (da) Fremgangsmaade til fremstilling af 4,1',6'-trichlor-4,1',6'-tridesoxygalactosaccharose
DK301077A (da) Fremgangsmade til fremstilling af 6a,10a-transhexahydrodibenzo (b,d) pyran-9-oner
DK467377A (da) Fremgangsmaade til fremstilling af 1,4,3,6-dianhydro-d-glucitol-2-nitrat.
NO145433C (no) Fremgangsmaate til fremstilling av 1,3-butadien.
DK153844C (da) Analogifremgangsmaade til fremstilling af 1,2,3,5-tetrahydroimidazothienopyrimidin-2-oner
DK161334C (da) Analogifremgangsmaade til fremstilling af i 11beta-stillingen substituerede 1,3,5(10)-triensteroider
DK159787C (da) Fremgangsmaade til fremstilling af 3',4'-dideoxykanamycin b
DK187577A (da) Fremgangsmade til fremstilling af 1,4-benzodioxsnderivater
DK156635C (da) Analogifremgangsmaade til fremstilling af 24,24-difluor-25-hydroxycholecalciferol
DK301277A (da) Fremgangsmade til fremstilling af substituerede 2,6-methano-2h-1-benzoxociner
DK233377A (da) Fremgangsmade til fremstilling af omega-noraromatiske-13,14-dehydro-prostaglandiner
DK185977A (da) Fremgangsmade til fremstilling af 1,3-dihydroheteroarylspiro (isobenzofuraner)
DK139029B (da) Analogifremgangsmåde til fremstilling af 5-m-tolyloxyuracil.
DK395877A (da) Fremgangsmaade til fremstilling af 2-(4-aroylpiperazin-1-yl)-4-amino-6,7-dimethoxyquinazoliner
DK146017C (da) Analogifremgangsmaade til fremstilling af 17alfa-acyloxy-9alfa,21-dihalogen-11beta-hydroxy-6alfa-fluor-16beta-methyl-pregna-1,4-dien-3,20-dion-forbindelser
DK73077A (da) Fremgangsmade til fremstilling af 2,9-dioxatricyclo (4,3,1,03,7) decaner
DK153838C (da) Analogifremgangsmaade til fremstilling af 2,4-dichlor-alfa-(n-imidazolylmethyl)-dibenzylethere
DK146067C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-5-phenoxypropoxypyrimidiner
DK146624C (da) Analogifremgangsmaade til fremstilling af 1-aminoalkyl-3,4-diphenyl-1h-pyrazoler
DK140578A (da) Fremgangsmaade til fremstilling af 2-(2!,2!,-trihalogenethyl)-4-halogencyclobutan-1-oner.
NO147381C (no) Fremgangsmaate for fremstilling av 2,6-ditert.-butylfenol.
DK280376A (da) Fremgangsmade til fremstilling af 1-acyl-1,2,3,4-tetrahydro-6-quinoliner
DK139586B (da) Analogifremgangsmåde til fremstilling af 2,2-dimethyl-19-nor-pregn-4-en-3,20-dioner.

Legal Events

Date Code Title Description
PUP Patent expired